Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
Recruiting now · Not applicable
Conditions studied: Aortic Aneurysm, Abdominal, Renal Insufficiency, Stent-Graft Thrombosis
In brief
This randomized controlled trial aim to determine the impact on renal function after treatment for infrarenal abdominal aortic aneurysm (AAA) with stentgrafts either with active supra- or infrarenal fixation.
Key facts
- Study ID
- NCT04754659
- Run by
- Vastra Gotaland Region
- People needed
- 252
- Starts
- 2022-12-19
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2024-05-07
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Willing and able to provide written informed consent
- Meet criteria for non-ruptured infrarenal/iliac aneurysm
- Suitable anatomy for treatment with an approved device (CE-marked) stentgraft according to the manufacturers' instructions for use for AAA.
- Accepted for treatment with endovascular aortic repair (EVAR) by the participating vascular center.
You may not qualify if…
- Ongoing or planned dialysis
- AAA treatment requiring stents or stentgrafts in renal and/or visceral arteries
- Inability to independently complete HRQoL questionnaires due to language barriers
- Anatomical preconditions that do not allow both types of fixation to be used interchangeably, i.e. very advanced suprarenal tortuosity (>60 degrees), advanced suprarenal dilatation or infrarenal thrombus >25% of circumference.
Where it is running
- Sahlgrenska University Hospital — Gothenburg, VastraGotaland, Sweden (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.